The Role of SGLT2 Inhibitors in the Management of Diabetic Retinopathy: A Literature Review
Pharmazie. 2026 May 19;81(5):51803. doi: 10.31083/Pharmazie51803.ABSTRACTDiabetic retinopathy (DR) remains a leading cause of blindness among individuals with diabetes mellitus (DM), with a continuously rising global prevalence. While anti-vascular endothelial growth factor (anti-VEGF) therapy, cort

